Sun Pharmaceutical Industries Share Price Today - Live Blog for December 01, 2025

With a -0.06% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,810.25. The stock is currently trading at a PE of 41.9100, while the industry PE is 33.4846, prompting investors to assess its value proposition.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.22% boost, with the current market value at ₹1,809.05 per share. This surge has not gone unnoticed by investors.

With a remarkable 0.24% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,805.40. Notably, this stock has a Price-to-Earnings (PE) ratio of 41.9100, while the industry's PE ratio is 33.4846.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.25%, signalling a challenging period. Currently trading at ₹1,802.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.12% gain, with the share price now at ₹1,807.10. Notably, the stock's PE ratio stands at 41.9100, and its Return on Equity (ROE) is 14.8407%.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.41%, signalling a challenging period. Currently trading at ₹1,802.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd stock stayed at its current value, with no movement, and is trading at ₹1,806.65. The stock has a PE ratio of 41.9100, an ROE of 14.8407%, and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.14% upswing, and it's currently trading at ₹1,808.10 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd observed a -0.27% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,805.80. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,810.65. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd observed a -0.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,811.05. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

After a -0.17% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,811.05. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.17%, signalling a challenging period. Currently trading at ₹1,813.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.00% surge in its share price and is presently trading at ₹1,816.00. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.05% uptick in its share price. As a result, it's now actively trading at ₹1,816.05 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd share price has declined by -0.11%, and it's currently trading at ₹1,816.45. The stock maintains a PE of 41.9100, while the industry PE is 33.4846, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.08%, and as of now, it's trading at ₹1,817.85 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd share price has declined by -0.11%, and it's currently trading at ₹1,816.65. The stock maintains a PE of 41.9100, while the industry PE is 33.4846, prompting discussions about its valuation.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,818.65, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd experienced a -0.01% downturn in its share price, and it's currently trading at ₹1,818.65. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.01%, a situation worth noting. At present, the stock is trading at ₹1,818.65. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 41.9100, while the industry PE ratio is 33.4846.

With a -0.09% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,818.80. The stock is currently trading at a PE of 41.9100, while the industry PE is 33.4846, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd shares saw a -0.09% decrease, reaching a current market price of ₹1,818.80. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

With a -0.09% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,818.80. This development raises questions about the factors behind the decline. The stock's PE ratio is 41.9100, while the industry PE is 33.4846.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.31%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,819.10, and market participants are assessing the implications. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,824.40. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 41.9100, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

With a -0.14% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,827.50. The stock is currently trading at a PE of 41.9100, while the industry PE is 33.4846, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.45%, signalling a challenging period. Currently trading at ₹1,831.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.43% decline, and it currently trades at ₹1,837.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.